mTOR Inhibitors Control the Growth of EGFR Mutant Lung Cancer Even after Acquiring Resistance by HGF
Daisuke Ishikawa(Tokyo Institute of Technology), Seiji Yano(Kanazawa University Hospital)
Cited by 33
Related Papers
Porphyrin-based sensor nanoarchitectonics in diverse physical detection modes
|Physical Chemistry Chemical Physics|2014|361
AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells
|Nature Communications|2019|360
Prediction of sensitivity of advanced non-small cell lung cancers to gefitinib (Iressa, ZD1839)
|Human Molecular Genetics|2004|174
Transient IGF-1R inhibition combined with osimertinib eradicates AXL-low expressing EGFR mutated lung cancer
|Nature Communications|2020|112